Ken Griffin Xoma Corp Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Xoma Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 1,000 shares of XOMA stock, worth $26,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 10,100 90.1%

Holding current value

$26,620

Previous $242,000 90.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.31 - $26.7 $50,487 - $60,422	2,263 Added 14.88%	17,473 $413,000
Q1 2024 May 15, 2024	SELL	$19.1 - $26.32 $216,345 - $298,126	-11,327 Reduced 42.68%	15,210 $365,000
Q4 2023 Feb 14, 2024	SELL	$13.82 - $19.13 $21,780 - $30,148	-1,576 Reduced 5.61%	26,537 $490,000
Q3 2023 Nov 14, 2023	SELL	$14.02 - $17.71 $123,347 - $155,812	-8,798 Reduced 23.84%	28,113 $396,000
Q2 2023 Aug 14, 2023	BUY	$17.0 - $21.58 $105,315 - $133,688	6,195 Added 20.17%	36,911 $697,000
Q1 2023 May 15, 2023	BUY	$18.01 - $23.12 $345,395 - $443,395	19,178 Added 166.22%	30,716 $648,000
Q4 2022 Feb 14, 2023	SELL	$16.0 - $25.45 $134,592 - $214,085	-8,412 Reduced 42.17%	11,538 $212,000
Q3 2022 Nov 14, 2022	SELL	$15.9 - $29.56 $44,456 - $82,649	-2,796 Reduced 12.29%	19,950 $357,000
Q2 2022 Aug 15, 2022	BUY	$17.05 - $28.22 $387,819 - $641,892	22,746 New	22,746 $507,000
Q3 2020 Nov 16, 2020	SELL	$16.25 - $20.94 $203,807 - $262,629	-12,542 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.45 - $25.51 $231,399 - $319,946	12,542 New	12,542 $248,000
Q1 2018 May 11, 2018	SELL	$19.86 - $35.92 $267,414 - $483,662	-13,465 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$19.71 - $36.79 $265,395 - $495,377	13,465	13,465 $479,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

6.45M

Call Options Held

Put Options Held

2.2K

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $305M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account